Dr Alexander Stockdale MBChB, MRes, PhD, DTM&H, MRCP (Inf. Dis.)
NIHR Senior Clinical Lecturer Clinical Infection, Microbiology & Immunology
- Work email A.Stockdale@liverpool.ac.uk
Research
Research Overview
I am interested in the effectiveness of the hepatitis B vaccine in African populations, the opportunity to implement additional measures to prevent mother to child transmission. My research tackles ways to reduce the disease burden through provision of effective and timely antiviral treatment for hepatitis B, where there is currently a huge unmet need.
I am a founder member of the HEPSANET group (Hepatitis B in Africa Collaborative Research Network). Details of the network can be found here: www.hepsanet.org.
Research Grants
Long-term outcomes of introducing tenofovir as part of ART in extensively lamivudine-experienced adults with HIV and HBV co-infection in Kumasi, Ghana: 4 year follow up of the HEPIK Cohort Study
EUROPEAN AIDS CLINICAL SOCIETY (BELGIUM)
October 2015 - October 2017